AstraZeneca pauses £200m Cambridge investment
Mitchell LabiakBusiness reporter and Simon JackBusiness editor Getty Images AstraZeneca has paused plans to invest £200m at a Cambridge research site in a fresh blow to the UK pharmaceutical industry. The project, which was set to create 1,000 jobs, was announced in March 2024 by the previous government alongside another project in Liverpool, which was…
